Emergent BioSolutions Files 8-K
Ticker: EBS · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Emergent BioSolutions filed an 8-K on 6/24 for a 6/23 event. Details TBD.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on June 24, 2025, reporting an event on June 23, 2025. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific details on transactions or financial figures provided in the excerpt.
Why It Matters
This 8-K filing indicates a regulatory update from Emergent BioSolutions, requiring investors to review the full document for any material changes or disclosures.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- June 23, 2025 (date) — Earliest event date
- June 24, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 240-631-3200 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The 8-K filing is primarily to report on "Other Events" and "Financial Statements and Exhibits" as of June 23, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on June 24, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Emergent BioSolutions Inc.
In which state was Emergent BioSolutions Inc. incorporated?
Emergent BioSolutions Inc. was incorporated in Delaware.
What is the principal executive office address for Emergent BioSolutions Inc.?
The principal executive office address is 300 Professional Drive, Gaithersburg, Maryland 20879.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Emergent BioSolutions Inc. (EBS).